News | April 19, 2007

Robotic, Caterpillar-Like Device Crawls Across Beating Heart to Deliver Minimally Invasive Treatment

April 20, 2007 — Scientists at Carnegie Mellon University Robotics Institute in Pittsburgh, PA, have created a robotic device that can be inserted onto a heart using minimally invasive surgery to deliver medical treatment. Resembling a robotic caterpillar, the 20-millimeter-long HeartLander can crawl across the surface of a beating heart, delivering drugs or attaching medical devices.

HeartLander, developed by Cameron Riviere and colleagues, has two suckers for feet, each pierced with 20 holes connected to a vacuum line, which holds it onto the outside of the heart. By moving its body segments it can crawl across the heart at up to seven inches per minute. Surgeons keep track of the device using X-ray video or a magnetic tracker, controlling the movements via a joystick.

HeartLander can reach all parts of the heart's surface, Riviere said. And because it's stationary relative to the heart's surface, there is no need to interfere with the organ's movement.

The researchers are now working on adding a radio-frequency probe to treat arrhythmias by selectively killing malfunctioning heart tissue. They also plan to add a camera.

The caterpillar device is inserted below the ribcage by keyhole surgery and is attached to the heart via a vacuum line to the suckers.

Riviere says the next stage will test the device using a sheep's heart; he hopes the HeartLander will be available for surgical use within three to four years.

The research is described in New Scientist magazine.

Related Content

Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems| May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Robotic-Assisted PCI With CorPath GRX Broadcast Live at TCT Asia-Pacific Summit
News | Robotic Systems| May 01, 2017
Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous...
Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Over Niobe II System
News | Robotic Systems| April 24, 2017
A recent study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France validated the advantages of...
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath GRX System
News | Robotic Systems| April 12, 2017
Corindus Vascular Robotics Inc. announced that the first robotic-assisted percutaneous coronary intervention (PCI)...
Stereotaxis, Niobe remote magnetic navigation system, Philips Allura Xper FD10 cardiovascular X-ray, interface, integration
News | Robotic Systems| January 20, 2017
Stereotaxis Inc. announced the release of an interface between its remote magnetic navigation system for...
Sponsored Content | Videos | Robotic Systems| November 22, 2016
Corindus Vascular Robotics received U.S.
Corindus, Corpath, robotic navigation, Robotic PCI, CorPath GRX
Technology | October 27, 2016
October 27, 2016 — Corindus Vascular Robotics Inc. announced it received 510(k) clearance from the U.S.
Niobe remote magnetic navigation system, cardiac abltion, Robert Wood Johnson University Hospital, New Jersey, 500 procedures
News | Robotic Systems| October 25, 2016
Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed...
bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system

 

Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Overlay Init